▁Introduction 7.8203125
: 1.90625
<0x0A> 6.52734375
Bre 8.6328125
ast 1.216796875
▁cancer 0.57763671875
▁is 0.3330078125
▁a 1.6494140625
▁pre 5.26953125
val 0.343994140625
ent 0.0011606216430664062
▁and 2.87890625
▁concerning 6.59375
▁disease 0.7177734375
▁affect 3.26171875
ing 0.001819610595703125
▁millions 1.9736328125
▁of 0.0989990234375
▁women 0.276123046875
▁world 0.998046875
wide 0.027008056640625
. 0.38720703125
▁It 2.1875
▁is 0.230712890625
▁cru 4.390625
cial 0.002162933349609375
▁to 0.3544921875
▁understand 1.26171875
▁the 0.154052734375
▁critical 7.02734375
▁factors 1.55078125
▁that 0.65673828125
▁contribute 1.26171875
▁to 0.00913238525390625
▁its 1.7578125
▁development 0.496337890625
, 1.482421875
▁including 1.46875
▁her 5.359375
ed 0.794921875
ity 0.0006451606750488281
, 0.51220703125
▁dise 11.15625
ases 0.04534912109375
▁of 3.611328125
▁the 0.2071533203125
▁m 4.7578125
amm 0.03369140625
ary 0.00475311279296875
▁g 0.08038330078125
lands 0.6328125
, 0.0892333984375
▁and 0.73876953125
▁h 2.560546875
orm 0.002086639404296875
onal 0.421875
▁factors 2.046875
. 0.1871337890625
▁Det 7.4453125
ect 1.306640625
ing 0.00341033935546875
▁early 3.0703125
▁met 8.4296875
ast 0.0654296875
asis 0.87255859375
▁and 2.0390625
▁assess 5.23046875
ing 0.008209228515625
▁the 0.6396484375
▁ag 4.265625
gress 0.0217742919921875
iveness 0.047607421875
▁of 0.06671142578125
▁the 0.71435546875
▁cancer 1.826171875
▁type 6.05078125
▁play 4.57421875
▁a 0.415283203125
▁p 2.62890625
iv 3.0875205993652344e-05
otal 4.458427429199219e-05
▁role 0.0094757080078125
▁in 0.0158538818359375
▁gu 4.921875
iding 0.00058746337890625
▁treatment 0.9853515625
▁dec 1.6435546875
isions 0.000209808349609375
▁and 1.083984375
▁impro 0.541015625
ving 0.0003886222839355469
▁patient 0.80712890625
▁out 0.1131591796875
comes 0.0006008148193359375
. 0.0175018310546875
<0x0A> 0.78662109375
Body 8.7734375
: 0.70166015625
<0x0A> 0.27490234375
I 4.859375
. 0.09564208984375
▁Her 1.73828125
ed 0.1480712890625
ity 0.0007295608520507812
▁as 3.947265625
▁a 0.056915283203125
▁Crit 3.87109375
ical 0.00013756752014160156
▁F 0.1156005859375
actor 4.565715789794922e-05
: 1.28515625
<0x0A> 0.1893310546875
H 1.140625
ered 0.0033016204833984375
ity 0.00024962425231933594
▁is 0.4228515625
▁a 0.277099609375
▁significant 1.1259765625
▁contrib 2.123046875
utor 0.3330078125
▁to 0.0249786376953125
▁the 0.453125
▁development 0.373779296875
▁of 0.0300140380859375
▁breast 0.017730712890625
▁cancer 0.0018205642700195312
. 0.5615234375
▁Gen 1.9462890625
etic 0.175537109375
▁mut 0.431396484375
ations 0.0031871795654296875
, 1.392578125
▁such 0.50341796875
▁as 0.0002846717834472656
▁in 4.1875
▁the 0.5556640625
▁BR 0.03338623046875
CA 0.0007343292236328125
1 0.100341796875
▁and 0.141357421875
▁BR 0.00557708740234375
CA 0.0002168416976928711
2 0.0017347335815429688
▁gen 0.005420684814453125
es 2.4080276489257812e-05
, 0.00731658935546875
▁increase 1.720703125
▁the 0.2198486328125
▁sus 7.28125
cept 1.4185905456542969e-05
ibility 8.761882781982422e-05
▁to 0.5302734375
▁the 1.4716796875
▁disease 0.049407958984375
▁substantial 8.53125
ly 4.863739013671875e-05
. 0.0843505859375
▁Ind 3.44921875
ividual 0.0009322166442871094
s 0.0009469985961914062
▁with 0.2313232421875
▁a 0.306396484375
▁family 0.1033935546875
▁history 0.0019130706787109375
▁of 0.0232696533203125
▁breast 0.0650634765625
▁cancer 0.1552734375
▁have 2.56640625
▁a 0.2880859375
▁higher 0.256591796875
▁risk 0.18798828125
▁of 0.045806884765625
▁developing 0.0225067138671875
▁the 0.182373046875
▁disease 0.068359375
▁due 3.8671875
▁to 0.00041675567626953125
▁inherited 1.5205078125
▁gen 0.57373046875
etic 0.2060546875
▁pre 3.478515625
dis 0.0009360313415527344
pos 0.5107421875
itions 0.0032825469970703125
. 0.12042236328125
▁Under 4.7578125
standing 0.008636474609375
▁the 0.387451171875
▁role 1.5673828125
▁of 0.0270843505859375
▁her 0.270263671875
ed 0.01212310791015625
ity 4.601478576660156e-05
▁in 0.1781005859375
▁breast 0.334228515625
▁cancer 0.0008502006530761719
▁development 1.44921875
▁can 1.900390625
▁help 0.77490234375
▁identify 1.876953125
▁high 1.4208984375
- 0.0011196136474609375
ris 7.390975952148438e-05
k 1.9550323486328125e-05
▁individuals 0.2105712890625
▁for 4.4921875
▁pro 4.76953125
active 0.0909423828125
▁screen 0.32470703125
ing 0.0170745849609375
▁and 0.126220703125
▁prevent 1.40234375
ive 0.473876953125
▁measures 0.1519775390625
. 0.2115478515625
<0x0A> 0.08099365234375
II 0.06085205078125
. 0.0008282661437988281
▁D 0.53857421875
ise 0.00127410888671875
ases 0.01309967041015625
▁of 0.01064300537109375
▁the 0.01397705078125
▁M 0.022857666015625
amm 0.00017309188842773438
ary 0.0007271766662597656
▁G 0.0031566619873046875
lands 0.043731689453125
: 0.1517333984375
<0x0A> 0.0032367706298828125
C 3.328125
ertain 0.3642578125
▁dise 0.32763671875
ases 4.792213439941406e-05
▁affect 3.7421875
ing 0.0098114013671875
▁the 0.005573272705078125
▁m 0.04693603515625
amm 0.00011134147644042969
ary 0.000152587890625
▁g 0.006649017333984375
lands 0.016815185546875
▁can 1.564453125
▁increase 0.61328125
▁the 0.02655029296875
▁risk 0.0253143310546875
▁of 0.0079498291015625
▁breast 0.77490234375
▁cancer 0.00067901611328125
. 0.3935546875
▁For 1.65234375
▁instance 0.83642578125
, 0.0005135536193847656
▁at 4.640625
yp 0.21240234375
ical 0.01308441162109375
▁hyper 0.164794921875
pl 0.0002808570861816406
asia 0.0214691162109375
, 0.7099609375
▁a 0.86865234375
▁pro 4.375
l 0.007404327392578125
ifer 0.0006175041198730469
ative 0.97705078125
▁condition 1.5205078125
▁character 3.12109375
ized 0.005367279052734375
▁by 0.00031256675720214844
▁ab 0.54833984375
normal 0.02099609375
▁cell 0.94189453125
▁growth 0.1805419921875
▁in 1.64453125
▁the 0.0186004638671875
▁breast 0.78564453125
▁t 1.357421875
issue 0.03924560546875
, 0.00853729248046875
▁is 1.44921875
▁associated 1.1298828125
▁with 0.0001494884490966797
▁a 0.9326171875
▁higher 0.41064453125
▁risk 0.042633056640625
▁of 0.0102081298828125
▁developing 0.46826171875
▁cancer 2.94921875
. 0.30224609375
▁Other 1.9091796875
▁ben 5.85546875
ign 1.6689300537109375e-06
▁conditions 0.71044921875
, 0.398193359375
▁like 3.646484375
▁pap 5.140625
ill 0.0017871856689453125
omas 0.47119140625
▁and 0.6875
▁fib 0.3359375
ro 0.315185546875
aden 0.0721435546875
omas 0.0380859375
, 0.00551605224609375
▁also 2.669921875
▁contribute 3.00390625
▁to 0.01270294189453125
▁an 1.9619140625
▁increased 0.227783203125
▁risk 0.03375244140625
. 1.2060546875
▁It 2.626953125
▁is 0.05908203125
▁important 2.69140625
▁for 2.1015625
▁health 1.130859375
care 0.0271759033203125
▁profession 0.90185546875
als 1.3113021850585938e-06
▁to 0.040802001953125
▁evaluate 3.609375
▁these 1.701171875
▁pre 4.41015625
- 0.56640625
can 0.93212890625
cer 0.01541900634765625
ous 0.028045654296875
▁conditions 0.2086181640625
▁and 0.708984375
▁closely 5.01171875
▁monitor 0.01666259765625
▁patients 1.0341796875
▁to 2.517578125
▁detect 1.0791015625
▁any 0.96142578125
▁m 3.947265625
align 0.0006513595581054688
ant 0.136474609375
▁transformation 1.451171875
. 0.197509765625
<0x0A> 0.0173492431640625
III 0.0306396484375
. 0.0008258819580078125
▁H 0.04571533203125
orm 2.1219253540039062e-05
onal 0.0066375732421875
▁Fact 0.0225982666015625
ors 5.447864532470703e-05
: 0.0626220703125
<0x0A> 0.00141143798828125
H 0.306884765625
orm 0.00023066997528076172
onal 0.2220458984375
▁factors 0.2342529296875
, 0.87548828125
▁especially 4.20703125
▁est 0.361328125
ro 0.01335906982421875
gen 1.7881393432617188e-05
, 0.7666015625
▁play 0.76953125
▁a 0.09222412109375
▁critical 1.7431640625
▁role 0.00034499168395996094
▁in 0.00013387203216552734
▁breast 1.00390625
▁cancer 0.0027370452880859375
▁development 0.029144287109375
. 0.0567626953125
▁Pro 5.41015625
long 0.0552978515625
ed 0.0006213188171386719
▁expos 0.07611083984375
ure 8.130073547363281e-05
▁to 0.0177764892578125
▁est 0.289794921875
ro 0.003963470458984375
gen 1.633167266845703e-05
▁without 7.3125
▁the 2.013671875
▁counter 1.8291015625
bal 0.29638671875
ancing 0.79296875
▁effects 0.865234375
▁of 0.00075531005859375
▁pro 0.0679931640625
g 0.0128173828125
ester 2.2649765014648438e-06
one 7.236003875732422e-05
▁can 0.4599609375
▁increase 0.9375
▁the 0.038482666015625
▁risk 0.013458251953125
. 4.13671875
▁Fact 4.91796875
ors 3.838539123535156e-05
▁contrib 3.8125
uting 1.2278556823730469e-05
▁to 0.00400543212890625
▁increased 2.3828125
▁est 0.25537109375
ro 0.0003845691680908203
gen 2.0265579223632812e-06
▁expos 1.8662109375
ure 0.0003108978271484375
▁include 0.734375
▁early 1.8349609375
▁men 0.1407470703125
ar 0.06744384765625
che 3.790855407714844e-05
, 0.094482421875
▁late 0.1591796875
▁men 0.03582763671875
op 0.0012331008911132812
ause 0.00024175643920898438
, 0.005695343017578125
▁n 3.974609375
ul 0.00047850608825683594
li 0.00318145751953125
par 0.003631591796875
ity 0.007137298583984375
, 0.180419921875
▁and 0.279541015625
▁h 3.91015625
orm 0.00792694091796875
one 0.255859375
▁replacement 0.137939453125
▁ther 0.0006923675537109375
apy 0.00621795654296875
. 0.302001953125
▁Under 1.728515625
standing 0.0010738372802734375
▁the 0.52294921875
▁impact 2.53515625
▁of 0.0080108642578125
▁h 0.44091796875
orm 9.5367431640625e-07
onal 0.082763671875
▁im 4.078125
bal 7.462501525878906e-05
ances 0.273681640625
▁on 0.65576171875
▁breast 0.1298828125
▁cancer 0.00965118408203125
▁can 2.82421875
▁aid 2.82421875
▁in 0.020965576171875
▁prevent 1.8408203125
ive 0.9599609375
▁strateg 2.578125
ies 1.2040138244628906e-05
, 1.9833984375
▁such 0.513671875
▁as 5.650520324707031e-05
▁h 1.6640625
orm 0.00015819072723388672
one 0.59033203125
- 1.63671875
mod 2.47265625
ulating 0.251953125
▁medic 1.4765625
ations 0.093505859375
▁or 2.138671875
▁l 0.56005859375
ifest 1.6689300537109375e-05
yle 0.00020301342010498047
▁modifications 0.890625
. 0.22412109375
<0x0A> 0.011932373046875
IV 0.258056640625
. 0.0017766952514648438
▁Import 4.140625
ance 0.0006318092346191406
▁of 0.0111083984375
▁Early 0.1651611328125
▁Met 1.0654296875
ast 0.000133514404296875
asis 0.002300262451171875
▁D 0.66650390625
ete 8.940696716308594e-06
ction 9.34600830078125e-05
: 0.15087890625
<0x0A> 0.0030078887939453125
E 0.230712890625
ar 0.0013456344604492188
ly 0.0008625984191894531
▁detection 0.302001953125
▁of 0.279052734375
▁met 0.5322265625
ast 5.459785461425781e-05
asis 0.10992431640625
▁in 2.296875
▁breast 0.0711669921875
▁cancer 0.0009737014770507812
▁is 0.248779296875
▁cru 0.455078125
cial 0.0002932548522949219
▁for 0.6572265625
▁improved 3.041015625
▁pro 3.49609375
gn 0.0006060600280761719
osis 0.0250396728515625
▁and 0.5185546875
▁treatment 1.3759765625
▁out 0.15869140625
comes 5.4836273193359375e-06
. 0.002117156982421875
▁Met 1.4033203125
ast 0.0007305145263671875
asis 0.0906982421875
▁refers 1.462890625
▁to 3.0040740966796875e-05
▁the 0.0264892578125
▁spread 0.038360595703125
▁of 0.01485443115234375
▁cancer 0.060638427734375
▁from 1.791015625
▁the 0.5166015625
▁breast 4.21484375
▁to 0.2474365234375
▁distant 2.359375
▁org 0.309326171875
ans 5.960464477539062e-07
▁or 4.5859375
▁t 0.1470947265625
issues 0.0115814208984375
, 0.84716796875
▁such 0.73828125
▁as 1.919269561767578e-05
▁the 0.054962158203125
▁l 0.44189453125
ungs 0.058349609375
, 0.1549072265625
▁b 1.8974609375
ones 0.05572509765625
, 0.0016527175903320312
▁or 0.55517578125
▁li 0.381591796875
ver 4.458427429199219e-05
. 0.0257110595703125
▁Det 2.591796875
ect 0.0096282958984375
ing 0.000244140625
▁met 0.357421875
ast 3.6597251892089844e-05
atic 3.146484375
▁breast 1.6083984375
▁cancer 0.0018491744995117188
▁at 1.1689453125
▁an 0.0635986328125
▁early 0.02740478515625
▁stage 0.0017576217651367188
▁allows 1.82421875
▁for 0.0989990234375
▁more 0.71728515625
▁effective 0.426513671875
▁treatment 0.31396484375
▁inter 5.47265625
vent 0.018157958984375
ions 1.3113021850585938e-06
▁and 1.5419921875
▁potentially 3.494140625
▁cur 2.74609375
ative 0.05938720703125
▁options 1.841796875
. 0.271728515625
▁Reg 4.2109375
ular 0.0006532669067382812
▁screen 0.383544921875
ing 0.06103515625
, 1.076171875
▁including 1.0673828125
▁imag 4.08984375
ing 5.614757537841797e-05
▁techniques 3.62890625
▁( 6.05078125
such 1.2685546875
▁as 0.00011169910430908203
▁m 0.1468505859375
amm 4.267692565917969e-05
ography 0.2109375
, 1.05859375
▁ul 0.2066650390625
tras 0.028411865234375
ound 0.01375579833984375
, 0.0138092041015625
▁or 1.4501953125
▁M 0.414306640625
RI 6.401538848876953e-05
) 0.7001953125
▁and 0.09710693359375
▁blood 2.65234375
▁tests 0.06988525390625
▁( 0.96728515625
like 2.412109375
▁meas 7.16015625
uring 0.0004992485046386719
▁tum 1.0068359375
or 0.0295257568359375
▁markers 0.07080078125
), 0.3232421875
▁helps 4.62890625
▁identify 0.69970703125
▁any 1.15234375
▁signs 0.7978515625
▁of 0.004306793212890625
▁distant 5.9375
▁spread 0.8984375
. 0.8173828125
<0x0A> 0.47314453125
V 0.04351806640625
. 0.0003254413604736328
▁Method 7.82421875
s 0.03216552734375
▁to 1.603515625
▁Det 3.27734375
erm 0.386962890625
ine 0.0010471343994140625
▁Can 2.939453125
cer 0.0008726119995117188
▁Ag 0.09918212890625
gress 0.01146697998046875
iveness 0.0014886856079101562
: 0.01309967041015625
<0x0A> 0.0006756782531738281
Ass 2.51953125
ess 0.00047469139099121094
ing 0.0158843994140625
▁the 0.033447265625
▁ag 0.0217742919921875
gress 0.0006504058837890625
iveness 0.007526397705078125
▁of 0.02252197265625
▁breast 0.2420654296875
▁cancer 0.0015239715576171875
▁is 0.3544921875
▁cru 0.548828125
cial 7.319450378417969e-05
▁for 0.97265625
▁tail 3.013671875
oring 0.17822265625
▁treatment 0.11688232421875
▁plans 0.99462890625
. 0.9599609375
▁Several 2.021484375
▁methods 0.97509765625
▁are 0.84912109375
▁util 4.01953125
ized 0.0009613037109375
▁to 0.33154296875
▁determine 0.32568359375
▁the 0.30029296875
▁ag 1.1376953125
gress 0.00507354736328125
iveness 0.00872039794921875
, 2.82421875
▁including 0.254150390625
: 4.06640625
<0x0A> 0.0198211669921875
a 2.841796875
) 0.9248046875
▁Hist 1.654296875
op 0.46435546875
ath 0.00011515617370605469
ological 0.59423828125
▁exam 1.6552734375
ination 0.0290985107421875
: 0.56494140625
▁This 1.7216796875
▁involves 0.8896484375
▁analyz 1.22265625
ing 1.895427703857422e-05
▁a 3.103515625
▁tum 4.06640625
or 0.00299072265625
▁sample 0.460693359375
▁obtained 2.484375
▁through 0.5380859375
▁bi 1.5087890625
ops 6.794929504394531e-06
y 0.0010709762573242188
, 3.203125
▁which 1.9306640625
▁provides 0.96826171875
▁information 0.70556640625
▁about 0.73681640625
▁its 2.150390625
▁size 0.68408203125
, 0.044158935546875
▁grade 2.615234375
, 0.0911865234375
▁presence 7.19921875
▁of 0.034881591796875
▁h 2.705078125
orm 0.0002465248107910156
one 0.034149169921875
▁re 0.0211639404296875
cept 0.03070068359375
ors 0.00044345855712890625
▁( 2.865234375
estro 1.3154296875
gen 4.172325134277344e-06
▁and 0.4599609375
▁pro 0.06536865234375
g 0.0005311965942382812
ester 0.00017940998077392578
one 0.0010232925415039062
▁re 2.431640625
cept 0.0267791748046875
ors 0.00021016597747802734
), 0.06005859375
▁and 0.068115234375
▁human 5.28515625
▁e 0.00933837890625
pid 0.0008935928344726562
erm 0.00016355514526367188
al 0.0005998611450195312
▁growth 0.002735137939453125
▁factor 0.00470733642578125
▁re 0.039642333984375
ceptor 0.1824951171875
▁ 0.1458740234375
2 0.0001308917999267578
▁( 0.15087890625
HER 0.00402069091796875
2 0.06341552734375
) 0.1859130859375
▁expression 2.27734375
. 0.15185546875
<0x0A> 0.233642578125
b 0.005504608154296875
) 0.0002655982971191406
▁M 2.7578125
ole 0.09161376953125
cular 1.895427703857422e-05
▁profil 1.6025390625
ing 4.8279762268066406e-05
: 0.064208984375
▁Te 4.98828125
chni 0.00022554397583007812
ques 0.00027251243591308594
▁like 0.92431640625
▁gene 1.5361328125
▁expression 0.14990234375
▁profil 0.269287109375
ing 5.4001808166503906e-05
, 0.8271484375
▁including 8.1796875
▁the 2.826171875
▁On 0.4775390625
cot 0.374267578125
ype 0.0022029876708984375
▁D 0.049713134765625
X 0.058868408203125
▁and 1.88671875
▁Mam 2.33203125
map 0.438232421875
r 0.0016088485717773438
int 0.007205963134765625
▁tests 0.197265625
, 0.00666046142578125
▁analyze 2.44140625
▁the 0.66650390625
▁expression 0.86279296875
▁pattern 4.28515625
▁of 0.006732940673828125
▁multiple 2.9921875
▁gen 0.0212860107421875
es 0.001110076904296875
▁in 2.158203125
▁the 1.0390625
▁tum 0.087158203125
or 0.0035419464111328125
. 3.146484375
▁These 1.396484375
▁tests 0.265625
▁provide 1.21875
▁additional 2.61328125
▁information 0.319091796875
▁about 0.35986328125
▁the 0.126708984375
▁lik 3.025390625
elihood 0.00232696533203125
▁of 0.00704193115234375
▁rec 1.7216796875
urrence 0.00652313232421875
▁and 0.27587890625
▁the 1.2490234375
▁potential 1.5634765625
▁benefit 1.896484375
▁of 0.06414794921875
▁specific 2.69140625
▁ther 1.236328125
ap 0.033660888671875
ies 1.2993812561035156e-05
. 0.06427001953125
<0x0A> 0.00969696044921875
Con 6.45703125
clusion 0.01561737060546875
: 0.0194854736328125
<0x0A> 1.2392578125
Recogn 6.19921875
izing 0.0173797607421875
▁and 2.658203125
▁understanding 0.91162109375
▁the 0.119384765625
▁critical 0.8603515625
▁factors 0.07354736328125
▁contrib 0.86279296875
uting 1.633167266845703e-05
▁to 0.0004153251647949219
▁breast 0.456298828125
▁cancer 0.0003654956817626953
▁development 0.1370849609375
, 1.3125
▁such 1.298828125
▁as 0.00019860267639160156
▁her 0.0391845703125
ed 0.00821685791015625
ity 1.0371208190917969e-05
, 0.005863189697265625
▁dise 0.249755859375
ases 0.00020384788513183594
▁of 0.0058441162109375
▁the 0.00527191162109375
▁m 0.0018157958984375
amm 3.0279159545898438e-05
ary 7.998943328857422e-05
▁g 0.0009131431579589844
lands 0.00455474853515625
, 0.0033550262451171875
▁and 0.426513671875
▁h 0.004528045654296875
orm 1.1920928955078125e-06
onal 0.006107330322265625
▁factors 0.2305908203125
, 0.0191802978515625
▁is 0.366943359375
▁cru 0.65625
cial 1.6927719116210938e-05
▁for 0.310546875
▁early 2.34765625
▁detection 0.12841796875
▁and 0.300048828125
▁effective 0.6171875
▁prevent 5.28125
ion 0.68408203125
▁strateg 0.95947265625
ies 3.5762786865234375e-06
. 0.00994873046875
▁Det 2.408203125
ect 0.0133056640625
ing 5.173683166503906e-05
▁early 0.31396484375
▁met 0.01349639892578125
ast 4.184246063232422e-05
asis 0.0197906494140625
▁and 0.1434326171875
▁accur 4.18359375
ately 1.1682510375976562e-05
▁assess 0.34765625
ing 0.00016307830810546875
▁the 0.129150390625
▁ag 0.0277862548828125
gress 0.00020134449005126953
iveness 0.002044677734375
▁of 0.007534027099609375
▁breast 1.71875
▁cancer 0.00794219970703125
▁aid 5.77734375
▁in 0.03216552734375
▁personal 2.919921875
izing 1.2353515625
▁treatment 0.0484619140625
▁plans 0.41455078125
▁and 0.496826171875
▁impro 0.1658935546875
ving 2.0384788513183594e-05
▁patient 0.2044677734375
▁out 0.009552001953125
comes 1.609325408935547e-05
. 0.008575439453125
▁Through 5.421875
▁on 2.625
going 0.0016565322875976562
▁research 0.0156402587890625
▁and 0.249267578125
▁aw 4.484375
aren 2.5033950805664062e-06
ess 4.649162292480469e-06
, 1.7548828125
▁we 0.1624755859375
▁can 0.033538818359375
▁continue 1.1552734375
▁to 0.07568359375
▁advance 1.59375
▁in 3.01171875
▁our 0.408447265625
▁understanding 0.37890625
▁of 0.273193359375
▁breast 0.482421875
▁cancer 0.00027632713317871094
▁and 0.1578369140625
▁improve 1.73046875
▁the 1.5234375
▁lives 0.7529296875
▁of 0.0010919570922851562
▁those 0.203125
▁affected 0.0927734375
▁by 0.72412109375
▁it 1.4580078125
. 0.00917816162109375
